Vimarsana.com

Latest Breaking News On - Enliven therapeutics inc - Page 6 : vimarsana.com

Enliven Therapeutics (NASDAQ:ELVN) Trading 7.2% Higher

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s share price was up 7.2% during mid-day trading on Tuesday . The stock traded as high as $18.00 and last traded at $18.00. Approximately 2,995 shares were traded during trading, a decline of 98% from the average daily volume of 138,926 shares. The stock had previously closed […]

Benjamin-hohl
Samuel-kintz
Citigroup-inc
Barclays-plc
Enliven-therapeutics-company-profile
Nasdaq
York-mellon-corp
Enliven-therapeutics-inc
Tower-research-capital
Dimensional-fund-advisors
Enliven-therapeutics
Get-free-report

Insider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Sells 4,875 Shares of Stock

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) COO Anish Patel sold 4,875 shares of the firm’s stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $15.11, for a total transaction of $73,661.25. Following the sale, the chief operating officer now owns 12,347 shares of the company’s […]

Anish-patel
Barclays-plc
Tower-research-capital
Nasdaq
Dimensional-fund-advisors
Enliven-therapeutics-company-profile
Enliven-therapeutics-inc
Citigroup-inc
York-mellon-corp
Enliven-therapeutics
Get-free-report
New-york-mellon-corp

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Richard A. Heyman Sells 1,270 Shares

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) Director Richard A. Heyman sold 1,270 shares of the firm’s stock in a transaction on Tuesday, January 30th. The stock was sold at an average price of $16.41, for a total value of $20,840.70. Following the completion of the sale, the director now directly owns 146,010 shares […]

Canada
China
Richarda-heyman
Royal-bank
Ameritas-investment-partners-inc
Nasdaq
Tower-research-capital
China-universal-asset-management-co
Life-insurance-co
Securities-exchange-commission
Enliven-therapeutics-company-profile

Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 4.5%

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s share price was down 4.5% during trading on Friday . The company traded as low as $15.59 and last traded at $15.61. Approximately 22,436 shares changed hands during trading, a decline of 80% from the average daily volume of 112,286 shares. The stock had previously closed at […]

Josephp-lyssikatos
Anish-patel
Life-insurance-co
Securities-exchange-commission
Deutsche-bank
Enliven-therapeutics-company-profile
Tower-research-capital
Group-plc
Enliven-therapeutics-inc
Mirae-asset-global-investments-co
Nasdaq
Enliven-therapeutics

Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Anish Patel Sells 4,875 Shares

Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Anish Patel Sells 4,875 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Anish-patel
Enliven-therapeutics-inc
Tower-research-capital
Citigroup-inc
Dimensional-fund-advisors
Barclays-plc
York-mellon-corp
Nasdaq
Enliven-therapeutics-company-profile
Enliven-therapeutics
Get-free-report
New-york-mellon-corp

Enliven Therapeutics (NASDAQ:ELVN) Trading Up 7.5%

Enliven Therapeutics (NASDAQ:ELVN) Trading Up 7.5%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Canada
China
Anish-patel
Samuel-kintz
China-universal-asset-management-co
Tower-research-capital
Royal-bank
Ameritas-investment-partners-inc
Nasdaq
Securities-exchange-commission
Enliven-therapeutics-inc
Enliven-therapeutics-company-profile

Benjamin Hohl Sells 9,383 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock

Benjamin Hohl Sells 9,383 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Blackrock
United-kingdom-general-
United-kingdom
Benjamin-hohl
Boxer-capital
Blackrock-inc
Enliven-therapeutics-company-profile
Enliven-therapeutics-inc
Nasdaq
Fairmount-funds-management
Enliven-therapeutics
Get-free-report

Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Sells $14,774.49 in Stock

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) COO Anish Patel sold 983 shares of Enliven Therapeutics stock in a transaction that occurred on Friday, December 22nd. The shares were sold at an average price of $15.03, for a total transaction of $14,774.49. Following the sale, the chief operating officer now owns 35,739 shares in […]

Canada
Anish-patel
Prelude-capital-management
Tower-research-capital
Enliven-therapeutics-company-profile
Ameritas-investment-partners-inc
Life-insurance-co
Enliven-therapeutics-inc
Royal-bank
Nasdaq
Securities-exchange-commission
Enliven-therapeutics

vimarsana © 2020. All Rights Reserved.